Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MDLZ | CP |
|---|---|---|
| Price | $61.00 | $88.03 |
| Change today | ▼ 0.72% | ▼ 0.28% |
| Market cap | $77.85B | $77.39B |
| Return, 3 months | -0.4% | +4.3% |
| Return, year to date | +15.3% | +20.6% |
| Return, 1 year | -2.0% | +21.0% |
| P/E (TTM) | 22.3 | 28.9 |
| P/B | 2.9 | 2.3 |
| P/E percentile vs own 5y | 47th | 80th |
| Dividend yield | 3.28% | 0.76% |
| Revenue growth (YoY, latest qtr) | +4.1% | +12.6% |
| Net profit growth (YoY) | +141.0% | -17.0% |
| Gross margin | 31.1% | 36.8% |
| Operating margin | 11.6% | 36.8% |
| Net margin | 8.9% | 25.0% |
| Return on equity | 13.3% | 8.3% |
| Analyst target vs. price | +15.6% | +16.7% |
| Analyst buy share | 80% | 76% |
| RSI (14) | 46 | 44 |
| 30-day volatility | 18.7% | 20.7% |
| Max drawdown, 1 year | -18.6% | -12.9% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.